Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.03 USD | -0.40% | +3.40% | +20.70% |
Apr. 17 | IGM Biosciences, Sanofi Narrow Partnership to Focus on Potential Immunology and Inflamation Targets | MT |
Apr. 17 | IGM Biosciences, Inc. Announces Refocusing of Sanofi Collaboration | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.70% | 591M | |
+9.15% | 106B | |
-1.08% | 104B | |
+6.93% | 23.25B | |
-11.55% | 22.5B | |
-7.22% | 18.7B | |
-37.08% | 17.95B | |
-9.91% | 16.99B | |
+7.55% | 14.26B | |
+40.04% | 12.76B |
- Stock Market
- Equities
- IGMS Stock
- News IGM Biosciences, Inc.
- Wedbush Cuts IGM Biosciences' PT to $19 From $37, Notes Focus of Aplitabart in mCRC, Removes Potential Imvotamab Oncology Revenues; Keeps Outperform Rating